1.Experimental study on the treatment of BioLiver Ⅰ bioartificial liver support system to two types of acute liver failure canine models
Shifeng ZHAO ; Yilong XUE ; Xiaopin CHEN
Medical Journal of Chinese People's Liberation Army 1981;0(06):-
Objective To assess the efficacy and safety of BioLiver Ⅰ bioartificial liver support system (BALSS) on the treatment of two types of acute liver failure (ALF) canine models. Methods The drug induced ALF canine model was established by multiple subcutaneous injections of acetaminophen. Another model was operated to resect 80 percent of the liver tissue. The primary hepatocytes were separated from the swine and cultured within the BALSS. The ALF models were treated by BioLiver ⅠBALSS for 6 hours. The changes of physiological, biochemical and histological parameters were observed before and after the treatment. Results The canines developed ALF 48 hours after injections of acetaminophen, the established rate of the model was 63 3%. While the other ALF canine model developed 24 hours after 80 percent liver resection and the established rate was 84 2%. Using our modified enzymatic digestion method, the yield of hepatocytes was (1 0~3 0)?10 10 per swine with high viability. BioLiver ⅠBALSS treatment resulted in beneficial effects on blood biochemical parameters. The pathological lesions of the liver were repaired. BALSS treatment was harmless to other organs. The ALF canines in drug group survived longer than in operation group. Conclusion This type of BALSS can provide safe and efficacious liver function support in the two types of ALF canine models, and it may be as an hepaful and important therapy to ALF
2.Video-assisted thoracoscopic diagnosis and treatment for esophageal tuberculosis: A report of 8 cases
Shifeng CHEN ; Yuequan JIANG ; Bing ZHU
Chinese Journal of Minimally Invasive Surgery 2005;0(08):-
Objective To evaluate the role of video-assisted thoracoscopic surgery (VATS) in the diagnosis and treatment of esophageal tuberculosis. Methods We had conducted video-assisted thoracoscopic surgery and acute pathological examinations for diagnosing and treating esophageal tuberculosis in 8 patients from June 1996 to April 2004. Results All the 8 patents were clarified as having secondary esophageal tuberculosis (Six of them had been misdiagnosed as having esophageal tumors preoperatively). A lymphoidectomy was carried out in 5 patents and a focus debridement, in 3 patents. The duration of procedure was 30~50 min (mean, 45 min). The intraoperative blood loss was 50~100 ml (mean, 80 ml). Postoperatively, pleural effusion occurred in 2 patients and wound infection took place in 1. Follow-up for 5~27 months (mean, 15 months) in 7 patients revealed a remarkable relief of dysphagia and no recurrence. Conclusions VATS in combination with acute pathological examinations is a rapid, safe, accurate and minimally invasive alternative for the diagnosis and treatment of esophageal tuberculosis.
3.Atypical Thymoma:Imaging Diagnosis and Compared with Pathology
Lumin MING ; Chengxin YAN ; Shifeng CHEN
Journal of Practical Radiology 2000;0(12):-
Objective To study the imaging findings of atypical thymoma.Methods 16 patients with atypical thymomas confirmed by pathology were involved in this study.Results In 16 cases,the all tumors appeared as soft tissue masses in anterior mediastinum,other imaging findings included lobulated sign in 12,calcification with in the tumors in 9,directly invasion to adjacent fatty tissue in 13 and mediastinum pleural and anterior chest wall in 7.The ipsilateral mediastinum pleural planting in 8,vascular involvement in 7 and pleural effusion in 6,pericardium effusion in 3 were showed.The tumors with smooth margins and clear surrounding fatty tissue were seen in 3,that were really simulating the benign thymoma.Conclusion Atypical thymoma are of certain imaging characteristics.
4.Treatment of rheumatoid gonarthritis by arthroscopic synovectomy combined with radiofrequency vaporization
Shiqiang CHEN ; Shifeng SONG ; Liyang YAO
Chinese Journal of Minimally Invasive Surgery 2005;0(10):-
Objective To investigate clinical effects of arthroscopic synovectomy combined with radiofrequency vaporization for the treatment of rheumatoid synovitis of the knee joint.Methods In 36 cases of rheumatoid gonarthritis with chronic synovitis of the knee joint,with simultaneous administration of regular medication,we had applied arthroscopic synovectomy combined with radiofrequency vaporization to remove the hyperplastic synovium and pannus through standard anteromedial and anterolateral approaches, and superolateral and superomedial approaches.In 21 out of 36 cases,diseased synovium in the posterior compartment was resected via additional posteromedial and posterolateral approaches.A systematic rehabilitation program was practiced 3 days after operation. Results All the 36 cases were followed for 4~26 months(mean,16 months).Clinical effects evaluation showed "excellent" in 21 cases,"good" in 13 cases,and "fair" in 2,with a total excellent-or-good rate of 94.4%(34/36).The knee joint function scores were significantly elevated from 58.6?5.3 preoperatively to 91.6?5.8 postoperatively(t=2.723,P=0.003).The Lysholm scores were significantly elevated from 42.3?3.8 preoperatively to 90.2?4.4 postoperatively(t=2.437,P=0.001).Conclusions Combined use of arthroscopic synovectomy with radiofrequency vaporization for the treatment of rheumatoid gonarthritis has advantages of minimal trauma,little blood loss,and rapid recovery of joint function.The procedure can effectively control the progression of rheumatoid arthritis and restore the knee joint function to the greatest possible extent.
5.Biological functions and drug development of Pyk2
Zhao ZHANG ; Shifeng CHU ; Naihong CHEN
Chinese Pharmacological Bulletin 2014;(6):744-747,748
Pyk2(Proline-rich tyrosine kinase 2) is an important member of focal adhesion kinase family. Pyk2 is highly ex-pressed in the central nervous system and the hematopoietic sys-tem . Pyk 2 can trigger a variety of SH 2 domain-containing pro-
teins to phosphorylate their substrates, thus it can participate in the regulations including ion channel activation, stress response, cell adhesion, cytoskeleton reorganization, vesicle transport and so on. Through the regulations above, the ability of cell migra-tion, survival, proliferation changes accordingly, suggesting that Pyk2 in many important regulatory processes may become a tar-get for clinical effects. Current drug development for Pyk2 main-
ly focuses on cancer, osteoporosis and immune response. This review illustrates the domain structure, regulatory mechanisms, potential drug targets, and the drug development of Pyk2 based on the above three fields, which will provide a theoretical basis for clinical treatment.
6.Advance in Glenohumeral Subluxation after Stroke (review)
Wenping ZHOU ; Shifeng KAN ; Wenhua CHEN
Chinese Journal of Rehabilitation Theory and Practice 2013;19(9):831-833
Glenohumeral subluxation is one of the most frequent complications in patients with post-stroke hemiplegia. This paper reviewed the recent advances in research on post-stroke Glenohumeral subluxation from the epidemiology, pathogenesis and related factors, diagnosis,treatment and so on.
7.The Practice and Methods of Physician-patient Shared Decision
Shifeng LOU ; Lin CHEN ; Shu CHEN ; Jianchuan DENG
Chinese Journal of Medical Education Research 2003;0(03):-
Probing into the methods and techniques of physician-patient communication is important to clinic medicine and medical education. Physician- patient shared decision is one of important aspects of physician-patient communication, 80 patients with hematologic malignancies were reviewed for classification of models of medical decision making, and the methods and techniques of physician-patient shared decision were also discussed .
8.Comparison of the effect of perindopril and metoprolol in the treatment of diabetic patients with asymptomat-ic cardiac insufficiency
Shifeng YE ; Rilai CHEN ; Zemin YANG ; Hui LIU ; Lifei HUANG
Chinese Journal of Primary Medicine and Pharmacy 2015;(17):2660-2663
Objective To compare the curative effect of perindopril and metoprolol in the treatment of diabetic patients with asymptomatic cardiac insufficiency.Methods According to the method of random numbers, 152 diabetic patients with asymptomatic cardiac insufficiency were divided into the observation group and control group,with 76 cases in each group.The observation group was given with perindopril treatment,while control group was given with metoprolol treatment.The cardiac function index,glycosylated hemoglobin,BNP levels,the incidence of cardiac insufficiency and the occurrence of adverse drug reactions before and after treatment were compared.Results There were no significant differences in LVEF,Tei index and E/A between two groups before treatment (all P >0.05 ).Compared with before treatment,the cardiac function indexes of the two groups were significantly improved after treatment(t=5.96,4.83,4.91,10.22,5.68,5.18,all P<0.05),but the observation group were improved more significantly(t=5.64,4.67,5.03,all P<0.05).Before and after treatment,there was no significant difference in the levels of glycosylated hemoglobin(all P>0.05),and the difference between the two groups was not statistically significant(all P>0.05).The BNP levels of the observation group before and after the treatment were (515.43 ± 58.85)pg/mL and (214.43 ±32.42)pg/mL respectively,of which the control group were (513.94 ±59.11)pg/mL and (263.32 ±43.31)pg/mL respectively,and after treatment,the BNP levels of the two groups were significantly decreased(t=23.45,17.68,all P<0.05),of which the observation group decreased more obvious(t=6.97,P<0.05).The cardiac insufficiency incidence of the observation group was 3.95%,which was significantly lower than 14.47% of the control group(χ2 =5.03,P<0.05).The incidence of adverse drug reactions had no obvious differ-ences in both groups(χ2 =0.08,P>0.05).Conclusion Using perindopril in treatment of diabetic patients with asymptomatic heart function can obviously improve cardiac function,reduce the incidence of BNP and cardiac insuffi-ciency.It has the clinical curative effect and high safety.
9.Preparation of LEM-GM-CSF and its inhibition effect on HL60/ADM cells in vitro
Shu CHEN ; Shifeng LOU ; Ying ZHANG ; Ping ZHANG
Journal of Third Military Medical University 2003;0(10):-
Objective To prepare liposome-entrapped mitoxantrone (LEM)-GM-CSF and observe the cytotoxicity of HL-60/ADM cells treated with LEM-GM-CSF, LEM and dihydroxyanthraquinone (DHAQ) in vitro. Methods LEM was prepared by reverse phase evaporation (REV). High speed centrifugation was applied to separate LEM and dissociate DHAQ. Colorimetry was employed to determine encapsulation efficiency. The liposome structure and particle size were determined by transmission electron microscopy. GM-CSF was coupled to LEM by glutaraldehyde method. UV-spectrophotometric analysis was applied to measure the coupled efficiency. Flow cytometry was applied to determine the immunoconjugate retained efficiency. The cytotoxicity of HL60/ADM cells and interdiction efficiency of GM-CSF were investigated by MTT test. Results The encapsulation efficiency of LEM was 80%. Most liposomes were monolayer, and the particle size was 170-220 nm. Its coupled efficiency with GM-CSF was 42.3%, and the immunoconjugate retained efficiency was 74.6%. All LEM-GM-CSF, LEM and DHAQ had cytotoxicity on HL60/ADM, their cytotoxic power in decrement sequence: LEM-GM-CSF, LEM, DHAQ. After treated with LEM-GM-CSF, LEM and DHAQ for 24 h, the IC50 of HL-60/ADM was 8.73, 12.42, 27.31 ?g/ml respectively and for 48 h the IC50 were 0.62, 8.25, 12.44 ?g/ml. The inhibition rate increased in a dose-dependent manner. Conclusion The encapsulation efficiency, the coupled efficiency and the immunoconjugate retained efficiency of LEM-GM-CSF prepared by our method were satisfying. LEM-GM-CSF representing anti-leukaemia efficiency in vitro had cytotoxicity on HL60/ADM cells.
10.Concentrations of sICAM-1 and sE-selectin in sera from patients with autoimmune rheumatic disease
Bo JIANG ; Hong WU ; Shifeng CHEN ; Longjing WU
Chinese Journal of Rheumatology 2001;0(04):-
Objective To evaluate the sera level of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) in patients with rheumatic diseases and to explore the correlation between the sera level of soluble adhesion molecules (sAM) and clinical findings. Methods The concentrations of sICAM-1 and sE-selectin in the sera of patients with rheumatic diseases (SLE, RA, PM/DM) and patients without rheumatic diseases, as well as the healthy controls were measured by the enzyme-linked immunosorbent assay (ELISA). After that, the correlation of the concentrations of sAM and clinical data as well as other laboratory parameters (RF, CK, anti-dsDNA) were analyzed. Results The concentrations of sICAM-1 and sE-selectin in all three group patients were significantly higher than those of non-autoimmune rheumatic diseases and healthy controls (P